- Service Name
Cell Shuttle™
- Industry
Life Sciences, Biotechnology, Cell Therapy Manufacturing, Automation Technology
- Main Value Proposition
Cellares offers unparalleled scalability, cost savings, and quality improvements in cell therapy manufacturing through its innovative Cell Shuttle™ platform.
- Description
Cell Shuttle™ is an advanced automated platform designed for industrial-scale cell therapy manufacturing. It integrates various technologies to enhance productivity, reduce costs, and improve quality in the production of cell therapies.
- Key Features
10x increase in productivity compared to conventional CDMOs; Up to 50% lower price per batch compared to conventional CDMOs; 75% lower process failure rates compared to conventional CDMOs; True end-to-end automation in a closed and automated single-use cartridge
- Use Cases
Manufacturing of CRISPR-edited CAR-T therapies; Production of various cell therapy modalities; Clinical-scale production for preclinical and clinical services
- Competitive advantages
Significantly higher productivity with a 10x increase; Substantial cost reductions of up to 50% per batch; Lower process failure rates, enhancing reliability and trust in manufacturing
- Strengths
Cellares' strengths lie in its advanced technology, significant cost savings, high scalability, and a strong commitment to quality, making it a leader in the cell therapy manufacturing space.
- Positioning
Cellares positions itself as a pioneering leader in the life sciences technology sector, specifically in the automation of cell therapy manufacturing.
- Audience
The primary target users include pharmaceutical companies, biotech firms, and research institutions focused on cell therapy development and production.
- CTA
Partner with us
- Tags
cell therapy
automation
manufacturing
biotechnology
- Tagline
Accelerating Access to Life-Saving Cell Therapies
- Tone of Voice
Innovative, authoritative, reliable
- Differentiation
Cellares is the first Integrated Development and Manufacturing Organization (IDMO), which uniquely combines development and manufacturing capabilities to overcome the limitations of conventional Contract Development and Manufacturing Organizations (CDMOs).
- Brand Positioning
Cellares embodies innovation and reliability in the life sciences industry, aiming to transform cell therapy manufacturing through advanced technology and strategic partnerships.
- Founded
2019-01-01
- Founders
Alex Pesch
Fabian Gerlinghaus
Omar Kurdi